SPIMACO - ADDWAEIH - Public Comps and Valuation Multiples

SPIMACO - ADDWAEIH Overview

About SPIMACO - ADDWAEIH

Saudi Pharmaceutical Industries & Medical Appliances Corp is involved in the manufacturing of basic chemical substances and products; medicines for human use, including cosmetics; pharmaceutical production and wholesale and retail of medicines and related products; development and marketing of medicinal and pharmaceutical products; research and development in medical science activities; operating and maintaining the healthcare facilities and any investments in related industries. The segments of the company are Pharmaceutical Manufacturing, Trading and Distribution services, and Healthcare Services, out of which the company derives maximum revenue from the Pharmaceutical Manufacturing segment. Its geographical segments are Saudi Arabia, Egypt, the Middle East, Morocco, and Algeria.

Founded

1986

HQ

Employees

n/a

Website

spimaco.com.sa

Sectors

Biopharmaceuticals
Drug Development & Therapeutics
Medical Devices
BioTech
HealthTech

Financials

LTM Revenue $478M

LTM EBITDA $82.6M

EV

$1.3B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

SPIMACO - ADDWAEIH Financials

As of September 2025, SPIMACO - ADDWAEIH reported last 12-month revenue of $478M and EBITDA of $82.6M.

In the same period, SPIMACO - ADDWAEIH generated $232M in LTM gross profit and $31.2M in net income.

See SPIMACO - ADDWAEIH valuation multiples based on analyst estimates

SPIMACO - ADDWAEIH P&L

In the most recent fiscal year, SPIMACO - ADDWAEIH reported revenue of $449M and EBITDA of $67.4M.

SPIMACO - ADDWAEIH expects next 12-month revenue of XXX and NTM EBITDA of XXX

See SPIMACO - ADDWAEIH valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$478M	XXX	$449M	XXX	XXX	XXX
Gross Profit	$232M	XXX	$223M	XXX	XXX	XXX
Gross Margin	49%	XXX	50%	XXX	XXX	XXX
EBITDA	$82.6M	XXX	$67.4M	XXX	XXX	XXX
EBITDA Margin	17%	XXX	15%	XXX	XXX	XXX
EBIT	$58.4M	XXX	$42.1M	XXX	XXX	XXX
EBIT Margin	12%	XXX	9%	XXX	XXX	XXX
Net Profit	$31.2M	XXX	$6.5M	XXX	XXX	XXX
Net Margin	7%	XXX	1%	XXX	XXX	XXX
Net Debt	XXX	XXX	$368M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for SPIMACO - ADDWAEIH including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $478M. EBITDA for the last twelve months was $82.6M. In the most recent fiscal year, SPIMACO - ADDWAEIH achieved $449M in revenue and $67.4M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$478M	Analyst estimates available to subscribers	$449M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$232M	Analyst estimates available to subscribers	$223M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	48.6% gross margin	Analyst estimates available to subscribers	49.8% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$82.6M	Analyst estimates available to subscribers	$67.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	17.3% EBITDA margin	Analyst estimates available to subscribers	15.0% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$58.4M	Analyst estimates available to subscribers	$42.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	12.2% EBIT margin	Analyst estimates available to subscribers	9.4% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$31.2M	Analyst estimates available to subscribers	$6.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	6.5% net profit margin	Analyst estimates available to subscribers	1.5% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$368M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for SPIMACO - ADDWAEIH

This financial data table provides comprehensive performance metrics for SPIMACO - ADDWAEIH, a company based in Saudi Arabia. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

SPIMACO - ADDWAEIH generated $478M in revenue over the last twelve months.
The company achieved $82.6M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $232M.
Net income over the last twelve months reached $31.2M.

Fiscal Year Performance

In the most recent fiscal year, SPIMACO - ADDWAEIH reported $449M in total revenue.
Fiscal year EBITDA was $67.4M.
The company maintained a gross profit margin of 49.8% in the most recent fiscal year.
EBITDA margin for the fiscal year was 15.0%.
Net profit margin reached 1.5% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for SPIMACO - ADDWAEIH. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

SPIMACO - ADDWAEIH Stock Performance

SPIMACO - ADDWAEIH has current market cap of SAR 3.6B (or $955M), and EV of SAR 4.7B (or $1.3B).

Market Cap Evolution

SPIMACO - ADDWAEIH Stock Data

As of October 17, 2025, SPIMACO - ADDWAEIH's stock price is SAR 30 (or $8).

See SPIMACO - ADDWAEIH trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.3B	$955M	XXX	XXX	XXX	XXX	$0.26

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

SPIMACO - ADDWAEIH Valuation Multiples

SPIMACO - ADDWAEIH's trades at 2.8x EV/Revenue multiple, and 18.7x EV/EBITDA.

See valuation multiples for SPIMACO - ADDWAEIH and 15K+ public comps

SPIMACO - ADDWAEIH Financial Valuation Multiples

As of October 17, 2025, SPIMACO - ADDWAEIH has market cap of $955M and EV of $1.3B.

Equity research analysts estimate SPIMACO - ADDWAEIH's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

SPIMACO - ADDWAEIH has a P/E ratio of 30.6x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$955M	XXX	$955M	XXX	XXX	XXX
EV (current)	$1.3B	XXX	$1.3B	XXX	XXX	XXX
EV/Revenue	2.6x	XXX	2.8x	XXX	XXX	XXX
EV/EBITDA	15.3x	XXX	18.7x	XXX	XXX	XXX
EV/EBIT	21.6x	XXX	29.9x	XXX	XXX	XXX
EV/Gross Profit	5.4x	XXX	n/a	XXX	XXX	XXX
P/E	30.6x	XXX	145.7x	XXX	XXX	XXX
EV/FCF	136.2x	XXX	-10.9x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get SPIMACO - ADDWAEIH Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

SPIMACO - ADDWAEIH Margins & Growth Rates

SPIMACO - ADDWAEIH's last 12 month revenue growth is 10%

SPIMACO - ADDWAEIH's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

SPIMACO - ADDWAEIH's rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

SPIMACO - ADDWAEIH's rule of X is 42% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for SPIMACO - ADDWAEIH and other 15K+ public comps

SPIMACO - ADDWAEIH Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	10%	XXX	9%	XXX	XXX	XXX
EBITDA Margin	17%	XXX	15%	XXX	XXX	XXX
EBITDA Growth	17%	XXX	38%	XXX	XXX	XXX
Rule of 40	21%	XXX	25%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	42%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	6%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	5%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	40%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial